In a new book, the conservative pundit Arthur C. Brooks offers tips to “young strivers” on maximizing their daily meaning ...

President Donald Trump did not, in fact, call in to C-SPAN on Friday using “John Barron” as a fake name, the network said. A man who identified himself with that name called in to C-SPAN after the ...

C.J. Stroud rightfully caught a ton of heat for his dismal postseason performance with the Houston Texans, which then brought about questions about his future. Due for a possible extension in the next ...

DEAR MISS MANNERS: I moved in with my boyfriend and discovered he has, in my opinion, a rather unusual habit. Not only does he say “bless you” in response to sneezes, but he does so in response to ...

Qatar announced two new 10-year golden visa pathways aimed at entrepreneurs and executives, without requiring investment for long-term residency. Here’s what to know. If you're looking to start or ...

AUSTIN – Acting Texas Comptroller Kelly Hancock announced that a record number of students have applied for the Texas Education Freedom Accounts (TEFA) since applications opened on Wednesday. The ...

The Take-Two Interactive earnings call will take place today, February 3, 2026, at 1:30 P.M. PT/4:30 P.M ET. We’ll be streaming it on the Shacknews Twitch channel. Take-Two will host the call ...

A police force has seen an increase in the number of 999 calls it receives, despite more of a focus on digital communications. Suffolk Police figures for 2025 show that 115,065 emergency calls were ...

The H-2A foreign worker program saw another year of growth in 2025, with the number of certified positions increasing by 13,300 workers to 398,258, a nearly 3.5% rise from the year before, the ...

I entered campus in 2022 as a Larkinite. Slowly but surely I adjusted to the relative craziness of college life: from RAs hanging hotdogs down my ceiling to the occasional OOD (out of distribution) On ...

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...

Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's ‌new fast-track program after agency scientists flagged safety and ...